Lice Infestations: Clinical Trials

9 trials for Lice Infestations, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 terminated, 1 unknown. 9 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 7, Terminated 1, Unknown 1
Phase 23Completed 2, Terminated 1

Follow Lice Infestations: new trials by email Literature Review of Lice Infestations trials Research Report on Lice Infestations

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Study for PIOLIN® Shampoo
PIOLIN®, NEDAX - PEDICULOSIS
Phase 3UnknownPhytopharm Consulting Brazil2122014-07-012013-10-23
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
Malathion gel 0.5%, Permethrin 1% rinse (Nix Crème) - Pediculosis
Phase 3CompletedSun Pharmaceutical Industries, Inc.4032009-08-012014-06-13
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
Malathion gel 0.5%, Permethrin 1% rinse - Pediculosis
Phase 3CompletedSun Pharmaceutical Industries, Inc.2542009-08-012014-08-04
Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
MALG (malathion) Treatment - Pediculosis
Phase 2 / Phase 3CompletedSun Pharmaceutical Industries, Inc.122008-09-012014-08-07
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
Spinosad, Permethrin 1% - Pediculosis
Phase 3CompletedParaPRO LLC5582007-09-012012-10-11
Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
MALG, Ovide (malathion) lotion 0.05%, Permethrin 1% - Lice Infestations
Phase 3CompletedSun Pharmaceutical Industries, Inc.3602005-12-012013-12-23
A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides.
1) MOOV Head Lice Treatment (Ego Pharmaceutical)., Banlice Mousse Aerosol (Pfizer, Australia), 3) KP24 Medicated Foam (Nelson Laboratories) - Pediculosis
Phase 2 / Phase 3CompletedUniquest Pty Ltd1522004-09-012006-12-12
Ivermectin in the Treatment of Head Lice
ivermectin, malathion - Lice Infestations
Phase 3CompletedJohnson & Johnson Consumer and Personal Products Worldwide8122004-02-012011-08-22
Two Treatment Regimens of Cocamide DEA Lotion for Head Lice
cocamide diethanolamine - Pediculosis, Head Louse Infestation
Phase 2 / Phase 3TerminatedMedical Entomology Centre1121999-10-012015-07-16

Broader conditions

Ectoparasitic Infestations (9)  ·  Infections (9)  ·  Parasitic Diseases (9)  ·  Skin Diseases (9)  ·  Skin Diseases, Infectious (9)  ·  Skin Diseases, Parasitic (9)  ·  Skin and Connective Tissue Diseases (9)

Interventions

Malathion (3)  ·  Permethrin (2)  ·  Ivermectin (1)  ·  Suspensions (1)  ·  Therapeutics (1)  ·  coconut diethanolamide (1)  ·  spinosad (1)

Sponsors

Sun Pharmaceutical Industries, Inc. (4)  ·  Johnson & Johnson Consumer and Personal Products Worldwide (1)  ·  Medical Entomology Centre (1)  ·  ParaPRO LLC (1)  ·  Phytopharm Consulting Brazil (1)  ·  Uniquest Pty Ltd (1)

Countries

United States (5)  ·  Australia (1)  ·  Brazil (1)  ·  France (1)  ·  Ireland (1)  ·  Israel (1)  ·  United Kingdom (1)

Top investigators

Bill Miller, MD (1)  ·  Ian F Burgess (1)  ·  Jerry Cottrell (1)  ·  Stephen Barker, PhD (1)

Results publications

PMID 17845167, PMID 20220184